Siqueira Helio Ribeiro de, Freitas Flávia Alvim Dutra de, Oliveira Denise Neves de, Barreto Angela Maria Werneck, Dalcolmo Margareth Pretti, Albano Rodolpho Mattos
Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
J Bras Pneumol. 2009 Jan;35(1):54-62. doi: 10.1590/s1806-37132009000100008.
To analyze the clinical characteristics and evolution of a group of patients with positive sputum cultures for multidrug-resistant (MDR) Mycobacterium tuberculosis and treated at a referral center in the city of Rio de Janeiro, Brazil.
Based on the positive results in sputum cultures for MDR M. tuberculosis, 50 patients were selected, and their clinical data were obtained from the Brazilian Ministry of Health MDR-TB Database. The frequencies of noncompliance, relapses, failures and previous treatments for TB up to diagnosis of MDR-TB were compiled. The radiological patterns were classified as unilateral or bilateral, and with or without cavitation. Two years after the end of the standard treatment for MDR-TB, the outcome (cure, failure, noncompliance or death) for each patient was evaluated and reassessed every two years. The post-treatment follow-up period was eight years.
The mean number of previous treatments was 2.3 +/- 0.9. The mean interval between the initial diagnosis and the development of MDR-TB was 2.0 +/- 1.7 years. Two years after the initial treatment for MDR-TB, 2 patients had abandoned treatment, 8 had died, 18 had been cured, and 22 had presented treatment failure. The bivariate analysis showed that bilateral pulmonary involvement and cavitary pattern markedly reduced the chances for cure, with a relative risk of 1-0.6 (40%) and 1-0.7 (30%), respectively. At the end of the follow-up period, 2 patients had abandoned treatment, 9 had presented treatment failure, 17 had been cured, and 22 had died.
Bilateral pulmonary involvement and cavity pattern greatly reduced the chances for cure of the patients with MDR-TB. Most patients who presented treatment failure died within the 8-year follow-up period.
分析一组痰培养耐多药结核分枝杆菌阳性且在巴西里约热内卢一家转诊中心接受治疗的患者的临床特征及病情演变。
基于痰培养耐多药结核分枝杆菌的阳性结果,选取50例患者,其临床数据来自巴西卫生部耐多药结核病数据库。汇总耐多药结核病诊断前结核病的不依从、复发、治疗失败及既往治疗次数。放射学模式分为单侧或双侧,有或无空洞形成。耐多药结核病标准治疗结束两年后,评估每位患者的治疗转归(治愈、失败、不依从或死亡),并每两年重新评估一次。治疗后随访期为八年。
既往治疗的平均次数为2.3±0.9次。初次诊断至耐多药结核病发生的平均间隔时间为2.0±1.7年。耐多药结核病初次治疗两年后,2例患者放弃治疗,8例死亡,18例治愈,22例治疗失败。双变量分析显示,双侧肺部受累及有空洞形成显著降低治愈几率,相对风险分别为1 - 0.6(40%)和1 - 0.7(30%)。随访期结束时,2例患者放弃治疗,9例治疗失败,17例治愈,22例死亡。
双侧肺部受累及有空洞形成大大降低了耐多药结核病患者的治愈几率。大多数治疗失败的患者在8年随访期内死亡。